Takeda Initiates TAK-536 Phase-III Clinical Trials In Japan
Published: 23-Jun-2009
TAK-536, a novel angiotensin receptor blocker intended to lower blood pressure
Takeda’ investigational compound, TAK-536 has entered into phase-III clinical trials in Japan. TAK-536 is a novel angiotensin receptor blocker (ARB) that is meant to lower blood pressure by inhibiting the action of the vasopressor hormone Angiotensin II.
TAK-536 is expected to show stronger anti-hypertensive action when compared to both Blopress and other existing ARBs, said the company.
Nancy Joseph-Ridge, General Manager of Pharmaceutical Development, Takeda, said: We will look forward to continuing the development of TAK-536, and to providing it as soon as possible to hypertensive patients in Japan in order to better control their blood pressure.”
Delicious
Digg
Reddit
Stumble
Facebook
LinkedInNetwork Sites
Mail sent successfully
Suppliers To This Sector
Browse A-Z
World Courier
Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...
WebWise Learning
Turning Information into Working Knowledge ...
Vetter Pharma International
High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...
Valsynthese
Hazardous Chemistry in Safe Hands ...
USB
Products from Affymetrix ...
Umicore Precious Metals Chemistry
Chemicals and Catalysts for Industrial Applications ...
White Papers
Browse A-Z
Your IP at Risk in Collaborations!
Free white paper: Ten steps to protect your R&D investment within partnerships. ...
Why, When and How to Conduct 14C Human Studies
Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...
Why CAPA Still Matters
This free white paper explores the needs and effectiveness of correct CAPA control, how to ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly
Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
